Moreover, recent guidelines state that no recommendation can be made to routinely measure this parameter, reposing on a recent analysis of 83 studies which found substantial heterogeneity in reporting and publication bias, making the magnitude of any independent association between high-sensitivity CRP and prognosis among patients with stable CAD uncertain [82]. This evidence concerns the gene CRP and coronary artery disorder.